FDA Recognizes August as National Immunization Awareness Month

August 4, 2022

National Immunization Awareness Month provides us an opportunity to think about how far the development and advancement of immunization science has come, and its impact on public health. The U.S. Food and Drug Administration plays a key role in immunization by evaluating vaccines for safety and effectiveness before they are made available to the public.

Vaccines work by stimulating the body’s immune system to safely provide protection against viruses or bacteria that cause infection. After vaccination, the immune system is prepared to respond quickly when the body encounters the disease-causing organism.

Why are vaccines important? They help provide protection from an infectious disease and can lessen the severity of illness. If you are immune to a disease, you can be exposed to it without becoming sick. Simply put, because of advances in medical science, vaccines can help protect us against more diseases than ever before. Some diseases that once injured or killed thousands of people have been eliminated primarily due to vaccines.

READ MORE

Interested in learning more? Contact us today to find out how we can help with your global regulatory needs.

TAGS:

June 8, 2022

Compounded drug search added to FDA’s NDC directory webpage

FDA recently added a search function to the National Drug Code (NDC) Directory webpage for human drugs compounded by outsourcing facilities that assign NDC numbers to their products. This update was...

White pills behind magnifying glass

June 18, 2025

FDA's Commissioner’s National Priority Voucher (CNPV) Pilot Program Overview

An inside look at FDA's new Commissioner's National Priority Voucher (CNPV) pilot program—what it is, why it matters, and how regulatory and development teams can leverage it to accelerate...

March 26, 2015

Learn Your Lessons Well: How Regulatory Strategies and Clinical Trial Design Affect Approvability

A recent analysis by the Tufts Center for the Study of Drug Development places the price tag of bringing a new drug to market at around $2.6 billion. The reason for this is simple: failure. Drugs...